Sichuan Kelun Pharmaceutical Co Ltd (002422.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE100000PW7
Sichuan Kelun Pharmaceutical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 21.81 bn CNY | 18.51 bn CNY |
| Gross profit | 11.20 bn CNY | 8.86 bn CNY |
| Operating income | 4.43 bn CNY | 2.49 bn CNY |
| EBIT | 4.04 bn CNY | 2.51 bn CNY |
| Net income | 2.94 bn CNY | 1.70 bn CNY |
| Diluted EPS – continuing operations | 1.86 CNY | 1.07 CNY |
Full history since 2007, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Sichuan Kelun Pharmaceutical Co Ltd
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes; over-the-counter products; and APIs to treat cardiovascular, IPF, ED, anti-tumor, anti-emetic, antibiotic, VB12, anti-rheumatoid arthritis, multiple sclerosis, anti-schizophrenia, CKD and anti-anemia, polypeptide, and other indications. It also provides ambroxol hydrochloride, potassium chloride, sodium chloride, magnesium sulfate, glucose, sterile water, sodium bicarbonate, lidocaine hydrochloride, vitamin B6, ribavirin, ceftazidime, 5% glucose, and ceftriaxone sodium injections. In addition, the company engages in investment; import and export; enterprise management; logistics and transportation; business services; agricultural non-staple food processing; production and sale of pharmaceutical intermediates; research and development of bio-based materials technology; Internet and related services; crop planting; professional technical; biotechnology extension; socio-economic consultation; technology promotion; medical research and testing exhibition; general cargo road transport; ecological protection and environmental management; and wholesale and retail. It exports its products to Japan. The company was formerly known as Sichuan Kelun Pharmaceutical Factory Co., Ltd and changed its name to Sichuan Kelun Pharmaceutical Co., Ltd. in August 2003. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. operates as a subsidiary of Sichuan Kelun Industry Group CO., LTD.
More stocks
- RANGE RESOURCES CORP (RRC)
- Camden Property Trust (CPT)
- Xizang Haisco Pharmaceutical Group Co Ltd (002653.SZ)
- U-Haul Holding Co /NV/ (UHAL-B)
- The Siam Cement Public Company Limited (SCC.BK)
- Indutrade AB (INDT.ST)
- Mitsubishi Chemical Group Corp (4188.T)
- Domino's (DPZ)
- Match Group, Inc. (MTCH)
- Impala Platinum Holdings Ltd (IMP.JO)
- DROPBOX, INC. (DBX)
- Orkla ASA (ORK.OL)
Not investment advice. All data without warranty, price as of 16.10.2026. Details in the risk notice.